Australia · Health Care · AUD (Thousands) · Annual
Key financials
AUD|Thousands
ROE
-263.3%
2026 (actual)
ROA
-188.39%
2026 (actual)
Gross Margin
-321.8%
2026 (actual)
Net Margin
-
Total Assets
A$4,776.85K
2026 (actual)
Net Income
-A$5,930.08K
2026 (actual)
Valuation
-
Stock Price
-
Historical & projected performance
AUD|Thousands
Reported figures and Equlion model projections for the next 5 years.
ROE
+299.6 pt
Company
ROA
-378.8 pt
Company
Gross Margin
+0 pt
Company
Sector average (own scale)
Total Assets
-52.4%
Company
Sector average (own scale)
Net Income
-110.6%
Company
Sector average (own scale)
Detailed data
AUD|Thousands
Amounts in AUD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for RHYTHM BIOSCIENCES LIMITED? It covers the balance sheet, income statement, cash flow and Equlion model projections.